AAPS Advances in the Pharmaceutical Sciences Series

Drug Product Development for the Back of the Eye

Editors: Kompella, Uday B., Edelhauser, Henry F. (Eds.)

  • Written by top investigators in respective areas
  • Addresses methods of tissue isolation and drug analysis, noninvasive approaches and nanotechnology based products
  • Presents approaches to assess and model pharmacokinetics of the eye noninvasively as well as a comprehensive coverage of transscleral drug delivery
see more benefits

Buy this book

eBook $259.00
price for USA (gross)
  • ISBN 978-1-4419-9920-7
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $329.00
price for USA
  • ISBN 978-1-4419-9919-1
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $329.00
price for USA
  • ISBN 978-1-4614-2819-0
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

This comprehensive volume discusses approaches for a systematic selection of delivery systems for various classes of therapeutic agents including small molecule, protein, and nucleic acid drugs. Specific topics covered in this book include:

  • Solution, suspension, gel, nanoparticle, microparticle, and implant dosage forms
  • Refillable and microneedle devices
  • Intravitreal, suprachoroidal, intrascleral, transscleral, systemic, and topical routes of delivery
  • Physical methods including iontophoresis for drug delivery
  • Rational selection of routes of administration and delivery systems
  • Noninvasive and continuous drug monitoring
  • Clinical endpoints and regulatory path to drug product development
  • Emerging and existing drugs and drug targets

 

Drug Product Development for the Back of the Eye is authored by renowned ocular drug delivery experts, representing academic, clinical, and industrial organizations and serves as indispensable resource for ophthalmic researchers, drug formulation scientists, drug delivery and drug disposition scientists, as well as clinicians involved in designing and developing novel therapeutics for the back of the eye diseases. This book is also relevant for students in various disciplines including ophthalmology, pharmaceutical sciences, drug delivery, and biomedical engineering.

 

Uday B. Kompella, Ph.D., Professor of Pharmaceutical Sciences & Ophthalmology, University of Colorado, developed functionalized nanoparticles, nanoporous microparticles, microparticles, injectable implants, dendrimers, liposomes, and in situ forming gels for the eye. He is a Fellow of the American Association of Pharmaceutical Scientists (2005) and the Association for Research in Vision and Ophthalmology (2010). He received Distinguished Scientist (2006) Award from the University of Nebraska.

 

Henry F. Edelhauser, Ph.D., Professor of Ophthalmology, Emory University, made pioneering contributions towards transcorneal, transscleral, and suprachoroidal drug delivery to the eye. He is a recipient of the Castroviejo Medal and the Alcon Research Award (1999), American Academy of Ophthalmology Senior Achievement Award (2000), and the Procter Medal (2005) for his outstanding ophthalmic translational research. He served as the president of the Association for Research in Vision and Ophthalmology (1990-91).

About the authors

Uday B. Kompella, Ph.D. has been an independent faculty member in the field of drug delivery for 17 years, with ocular drug delivery being a key research focus. Prior to joining University of Colorado in 2008, he served as a faculty member at University of Nebraska for 10 years and at Auburn University for 4 years. Dr. Kompella’s research, published in over 100 peer-reviewed articles, is focused on developing new drug and gene delivery approaches for treating neovascular diseases including diabetic retinopathy, age-related macular degeneration, and cancer. Dr. Kompella developed and assessed several drug delivery systems including functionalized nanoparticles, nanoporous microparticles, microparticles, injectable implants, dendrimers, liposomes, and in situ forming gels for ophthalmic applications. Dr. Kompella is a Fellow of the American Association of Pharmaceutical Scientists (2005) and the Association for Research in Vision and Ophthalmology (2010). He was recognized as a Distinguished Scientist in 2006 and as a Distinguished Teacher in 2003 at University of Nebraska Medical Center.

Henry F. Edelhauser, Ph.D. is a world leader in ophthalmic drug delivery, with an academic career spanning over 4 decades in ophthalmic research. After serving as a faculty member at the Medical College of Wisconsin (1966-1989) as an assistant, associate and then full professor, Dr. Edelhauser joined Emory University in 1989 as the Ferst Professor of Ophthalmology and Director of Ophthalmic Research. Dr. Edelhauser published over 230 peer-reviewed articles in the areas of ophthalmic drug delivery, surgical pharmacology, corneal physiology, and ocular toxicology. Dr. Edelhauser made pioneering contributions towards transcorneal, transscleral, and suprachoroidal drug delivery to the eye. During 1990-91, Dr. Edelhauser served as the president of the Association for Research in Vision and Ophthalmology (ARVO).  In 1999 he was awarded the Castroviejo Medal and the Alcon Research Award. In 2000, he received the senior achievement award from the American Academy of Ophthalmology. In 2005, Dr. Edelhauser was recognized with the Procter medal, ARVO's highest honor for his outstanding ophthalmic translational research from basic science to clinical applications.

Henry F. Edelhauser, Ph.D. is a world leader in ophthalmic drug delivery, with an academic career spanning over 4 decades in ophthalmic research. After serving as a faculty member at the Medical College of Wisconsin (1966-1989) as an assistant, associate and then full professor, Dr. Edelhauser joined Emory University in 1989 as the Ferst Professor of Ophthalmology and Director of Ophthalmic Research. Dr. Edelhauser published over 230 peer-reviewed articles in the areas of ophthalmic drug delivery, surgical pharmacology, corneal physiology, and ocular toxicology. Dr. Edelhauser made pioneering contributions towards transcorneal, transscleral, and suprachoroidal drug delivery to the eye. During 1990-91, Dr. Edelhauser served as the president of the Association for Research in Vision and Ophthalmology (ARVO).  In 1999 he was awarded the Castroviejo Medal and the Alcon Research Award. In 2000, he received the senior achievement award from the American Academy of Ophthalmology. In 2005, Dr. Edelhauser was recognized with the Procter medal, ARVO's highest honor for his outstanding ophthalmic translational research from basic science to clinical applications.

Henry F. Edelhauser, Ph.D. is a world leader in ophthalmic drug delivery, with an academic career spanning over 4 decades in ophthalmic research. After serving as a faculty member at the Medical College of Wisconsin (1966-1989) as an assistant, associate and then full professor, Dr. Edelhauser joined Emory University in 1989 as the Ferst Professor of Ophthalmology and Director of Ophthalmic Research. Dr. Edelhauser published over 230 peer-reviewed articles in the areas of ophthalmic drug delivery, surgical pharmacology, corneal physiology, and ocular toxicology. Dr. Edelhauser made pioneering contributions towards transcorneal, transscleral, and suprachoroidal drug delivery to the eye. During 1990-91, Dr. Edelhauser served as the president of the Association for Research in Vision and Ophthalmology (ARVO).  In 1999 he was awarded the Castroviejo Medal and the Alcon Research Award. In 2000, he received the senior achievement award from the American Academy of Ophthalmology. In 2005, Dr. Edelhauser was recognized with the Procter medal, ARVO's highest honor for his outstanding ophthalmic translational research from basic science to clinical applications.

Table of contents (22 chapters)

  • Selection of Drug Delivery Approaches for the Back of the Eye: Opportunities and Unmet Needs

    Marsh, David A.

    Pages 1-20

  • Microdialysis for Vitreal Pharmacokinetics

    Vaishya, Ravi D. (et al.)

    Pages 21-45

  • Fluorophotometry for Pharmacokinetic Assessment

    McCarey, Bernard E.

    Pages 47-84

  • Systemic Route for Retinal Drug Delivery: Role of the Blood-Retinal Barrier

    Tachikawa, Masanori (et al.)

    Pages 85-109

  • Topical Drug Delivery to the Back of the Eye

    Gadek, Thomas (et al.)

    Pages 111-124

Buy this book

eBook $259.00
price for USA (gross)
  • ISBN 978-1-4419-9920-7
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $329.00
price for USA
  • ISBN 978-1-4419-9919-1
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $329.00
price for USA
  • ISBN 978-1-4614-2819-0
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Drug Product Development for the Back of the Eye
Editors
  • Uday B. Kompella
  • Henry F. Edelhauser
Series Title
AAPS Advances in the Pharmaceutical Sciences Series
Series Volume
2
Copyright
2011
Publisher
Springer US
Copyright Holder
American Association of Pharmaceutical Scientists
eBook ISBN
978-1-4419-9920-7
DOI
10.1007/978-1-4419-9920-7
Hardcover ISBN
978-1-4419-9919-1
Softcover ISBN
978-1-4614-2819-0
Series ISSN
2210-7371
Edition Number
1
Number of Pages
XII, 592
Topics